Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Alkermes (8AK) vs. Competitors

0 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DE:8AKAlkermesEUR 42.42EUR 7.17B15676.6758.28%Moderate BuyUnlock the DE:8AK analyst price target with TipRanks PremiumDE:8AKUnlock the DE:8AK top-analyst price target with TipRanks Premium
RDYDr Reddy's Laboratories$14.74$12.18B41.076.27%Moderate BuyUnlock the RDY analyst price target with TipRanks PremiumDE:8AK vs RDYUnlock the RDY top-analyst price target with TipRanks Premium
VTRSViatris$20.82$23.87B-39.2890.83%Moderate BuyUnlock the VTRS analyst price target with TipRanks PremiumDE:8AK vs VTRSUnlock the VTRS top-analyst price target with TipRanks Premium
SUPNSupernus$29.72$6.07B8.12-0.37%Strong BuyUnlock the SUPN analyst price target with TipRanks PremiumDE:8AK vs SUPNUnlock the SUPN top-analyst price target with TipRanks Premium
TAKTakeda Pharmaceutical Company$21.43$69.21B28.2950.49%Moderate BuyUnlock the TAK analyst price target with TipRanks PremiumDE:8AK vs TAKUnlock the TAK top-analyst price target with TipRanks Premium

Performance Comparison

-25%0%25%50%75%100%125%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DE:8AKAlkermes42.4217.8272.44%
RDYDr Reddy's Laboratories14.740.866.17%
VTRSViatris20.8210.53102.23%
SUPNSupernus29.725.3722.06%
TAKTakeda Pharmaceutical Company21.437.2951.56%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts